Effect of Arestin Domain-Containing 4 Protein on Glucose Metabolism
Effect of Arestin Domain-Containing 4 Protein on Glucose Metabolism
批准号:
10490841
负责人:
Sezin Dagdeviren
金额:
$7.64万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-30 至 2024-10-28
关键词:
Adaptor Signaling ProteinAgeArrestinsBindingBody WeightCollaborationsDataDefectDiabetes MellitusEndocytosisEquilibriumFamilyFamily memberFastingFeedbackFellowshipFructoseG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGTP-Binding Protein alpha Subunits, GsGeneticGlucagonGlucagon ReceptorGlucoseGoalsHepaticHomologous GeneHormonalImpairmentIn VitroInjectionsInsulinInvestigationKnockout MiceLaboratoriesLifeLightLinkLipidsLiverLoxP-flanked alleleMammalsMediatingMediator of activation proteinMembraneMembrane ProteinsMetabolicMetabolismModelingMolecularMouse ProteinMusObesityPathway interactionsPlayPostdoctoral FellowProtein FamilyProteinsPyruvateRegulationRegulatory PathwayReportingResearchResistanceRoleSeriesSignal PathwaySignal TransductionTXNIP geneTestingTissuesUbiquitinationVisualbeta-arrestinblood glucose regulationexperimental studyfeedingglucose metabolismglucose productionglucose toleranceglucose uptakehepatic gluconeogenesishuman malein vivomembermetabolic phenotypemouse modelreceptorreceptor internalizationresponsetherapeutic developmenttraffickingubiquitin ligaseubiquitin-protein ligase
中文摘要
项目摘要
Arrestin蛋白超家族控制着跨-
膜受体,以及其他细胞内信号传导功能。的几名成员
目前已知ARRDC 3和TXNIP家族在代谢中具有重要作用。
ARRDC 4是一种研究不足的蛋白质,已显示其在体外抑制葡萄糖摄取,
与泛素连接酶相互作用,并在膜受体运输中起作用。体内
ARRDC 4的功能和分子机制尚不清楚。我的初步实验
显示与野生型相比,具有ARRDC 4系统性缺失的小鼠是胰高血糖素抗性的
对照肝细胞生成和胰高血糖素信号传导减少,
在ARRDC 4KO小鼠的肝组织中也观察到葡萄糖产生抑制。我
现在已经为这个项目生成了一个新的条件删除ARRDC 4小鼠模型。
胰高血糖素受体是GPCR,因此是与arrestin家族相互作用的潜在靶点
proteins.由于ARRDC 4与膜蛋白和7 TM受体相互作用,
我的研究的一个目的是回答ARRDC 4是否通过与胰高血糖素相互作用来控制胰高血糖素信号传导
受体或其下游介质。该项目的具体目标将集中在解开
ARRDC 4在体内肝脏葡萄糖代谢中的作用及其机制
在分子水平上的调节。因为ARRDC 4本身受葡萄糖和胰岛素调节,
确定ARRDC 4的代谢功能有可能揭示代谢反馈
葡萄糖代谢中与胰高血糖素信号传导相互作用的环。
英文摘要
Project Summary
The Arrestin superfamily of proteins controls the trafficking, turnover and signaling of trans-
membrane receptors, as well as other intracellular signaling functions. Several members of the
family, including ARRDC3 and TXNIP, are now known to have important roles in metabolism.
ARRDC4 is an understudied protein that has been shown to inhibit glucose uptake in vitro,
interact with ubiquitin ligases and plays a role in membrane receptor trafficking. The in vivo
functions and the molecular mechanisms of ARRDC4 are unknown. My preliminary experiments
reveal that mice with systemic deletion of ARRDC4 are glucagon resistant compared to wildtype
controls. Decreased hepatic gluconeogenesis and glucagon signaling and defects in hepatic
glucose production suppression were also observed in the liver tissues of ARRDC4KO mice. I
have now generated a new conditional deletion ARRDC4 mouse model for this project.
The glucagon receptor is a GPCR, and therefore a potential target to interact with arrestin family
proteins. As ARRDC4 interacts with membrane proteins and 7TM receptors, an important goal
of my research is to answer if ARRDC4 controls glucagon signaling by interacting with glucagon
receptors or its downstream mediators. The specific aims of this project will focus on unraveling
the functions of ARRDC4 in hepatic glucose metabolism in vivo and the mechanism of ARRDC4
regulation at the molecular level. Because ARRDC4 is itself regulated by glucose and insulin,
defining the metabolic functions of ARRDC4 has the potential to reveal a metabolic feedback
loop in glucose metabolism that interfaces with glucagon signaling.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effect of Arestin Domain-Containing 4 Protein on Glucose Metabolism
-
批准号:10387728
-
项目类别:
-
资助金额:$7.05万
-
财政年份:2021
-
负责人:Sezin Dagdeviren
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: